Founders of molecular diagnostics company ChromaCode share ambitions for their business

ChromaCode’s founders seek to break the paradigm of limited access to the most powerful diagnostic tools by deploying inexpensive reagent kits and software using traditional PCR detection systems so physicians can initiate testing using the most informative diagnostics without having to worry about access or cost.